| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| EG-016 | EG-016; Ad-VEGF-A | Phase 2 Clinical | Ark Therapeutics Ltd | Peripheral Vascular Diseases | Details |
| EG-011 | EG-011; Ad-VEGF-D | Phase 2 Clinical | Ark Therapeutics Ltd | Angina Pectoris | Details |